5 articles related to "ARV"
Patients sent home without drugs while pharmaceutical company AbbVie refuses to license patent to generic companies Johannesburg, 27 October 2015—After six months of persistent supply...
Press Release – Last updated 29 October 2015
A call to keep the Global Fund effective at saving lives in all developing countries through its 2017-2021 strategy. Download this letter as a PDF Geneva, 29th of July 2015, Dear Board of...
Statements, Speeches, Letters – Last updated 07 August 2015
As HIV burden overwhelmingly shifts to ‘middle-income’ countries, access to affordable medicines is under threat
Vancouver, 21 July, 2015 - At the International AIDS Society (IAS) Conference today, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières...
Press Release – Last updated 02 November 2016
In this issue brief, we review trends in generic competition and intellectual property (IP) licensing for key antiretroviral drugs. We then outline seven momentous decisions to be made in...
Briefing – Last updated 15 July 2015
The MSF Access Campaign monitors the patent barriers, prices and availability of antiretroviral (ARV) medicines and pushes for the uptake of policies that promote access to affordable quality medicines....
Static page – Last updated 18 July 2016